AstraZeneca Respiratory Head: Tezepelumab Could Be 'Game Changer'

 
• By Sten Stovall
Asthama
Tezepelumab Likely To Enter Phase III Testing In Severe Asthma Late In 2017 Or Early 2018 • Source: Shutterstock

More from Clinical Trials

More from R&D